Developing the 2013 WHO consolidated antiretroviral guidelines
Commentary
Early initiation of antiretroviral therapy in HIV-infected adults and adolescents
Commentary
Safety of efavirenz in the first trimester of pregnancy
Commentary
Optimization of antiretroviral therapy in HIV-infected children under 3 years of age
Commentary
Optimal strategies for monitoring response to antiretroviral therapy in HIV-infected adults, adolescents, children and pregnant women
Predicting treatment failure in adults and children on antiretroviral therapy
Commentary
Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization
Interventions to improve adherence to antiretroviral therapy
Community and service provider views to inform the 2013 WHO consolidated antiretroviral guidelines
Adoption of national recommendations related to use of antiretroviral therapy before and shortly following the launch of the 2013 WHO consolidated guidelines
The impact and cost of the 2013 WHO recommendations on eligibility for antiretroviral therapy
Health systems implications of the 2013 WHO consolidated antiretroviral guidelines and strategies for successful implementation